NutriBand Inc. (NTRB) stock
NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 4/30183% above fair value
$4.82−0.77 (-13.77%)
Close on Nov 18, 2026Market cap $58.59MP/E –Yield –
NutriBand shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
NutriBand's shares outstanding was 12M at Jul 31, 2026. For fiscal 2026 it was 12M, up 9.7% from the year before. The highest annual figure on record is 12M in fiscal 2026.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 12M | +9.7% |
| FY2025 | Jan 31, 2025 | 11M | +33.4% |
| FY2024 | Jan 31, 2024 | 8M | -6.0% |
| FY2023 | Jan 31, 2023 | 8M | +6.6% |
| FY2022 | Jan 31, 2022 | 8M | +37.5% |
| FY2021 | Jan 31, 2021 | 6M | +6.4% |
| FY2020 | Jan 31, 2020 | 5M | +1.3% |
| FY2019 | Jan 31, 2019 | 5M | +11.4% |
| FY2018 | Jan 31, 2018 | 5M | -9.4% |
| FY2017 | Jan 31, 2017 | 5M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | 12M | +8.4% |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | 12M | +9.3% |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | 12M | +9.5% |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | 12M | +8.6% |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | 11M | +1.4% |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | 11M | +21.5% |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | 11M | +33.5% |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | 11M | +41.7% |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | 11M | +41.2% |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | 9M | +16.9% |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | 8M | +5.8% |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | 8M | +0.4% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | 8M | -6.8% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | 8M | -14.7% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | 8M | -9.4% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | 8M | +23.3% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | 8M | +27.5% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | 9M | +66.4% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | 9M | +57.4% |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | 6M | +15.7% |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | 7M | +11.8% |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | 6M | +1.7% |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | 6M | +1.7% |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | 5M | +0.8% |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | 6M | +5.1% |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | 5M | -0.6% |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | 5M | +2.1% |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | 5M | +3.9% |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | 6M | -6.7% |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | 5M | +5.1% |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | 5M | +8.6% |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | 5M | +34.1% |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | 6M | +35.1% |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | 5M | -7.2% |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | 5M | -12.6% |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | 4M | – |
| Q4 FY2017CQ4 2016 | Jan 31, 2017 | 4M | – |
| Q3 FY2017CQ3 2016 | Oct 31, 2016 | 6M | – |
| Q2 FY2017CQ2 2016 | Jul 31, 2016 | 6M | – |
See a number that looks wrong?